Chemoinformaics analysis of 16-HYDROXY-HEXADECANOIC-ACID
| Molecular Weight | 325.537 | nRot | 15 |
| Heavy Atom Molecular Weight | 286.225 | nRig | 5 |
| Exact Molecular Weight | 325.298 | nRing | 1 |
| Solubility: LogS | -6.322 | nHRing | 1 |
| Solubility: LogP | 6.716 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 39 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 62.1089 |
| nHD | 1 | BPOL | 42.0011 |
| QED | 0.395 |
| Synth | 2.552 |
| Natural Product Likeliness | 0.541 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.79 |
| MDCK | 0.0000148 |
| BBB | 0.346 |
| PPB | 0.854845 |
| VDSS | 2.249 |
| FU | 0.120077 |
| CYP1A2-inh | 0.184 |
| CYP1A2-sub | 0.339 |
| CYP2c19-inh | 0.358 |
| CYP2c19-sub | 0.144 |
| CYP2c9-inh | 0.061 |
| CYP2c9-sub | 0.856 |
| CYP2d6-inh | 0.862 |
| CYP2d6-sub | 0.167 |
| CYP3a4-inh | 0.633 |
| CYP3a4-sub | 0.178 |
| CL | 3.824 |
| T12 | 0.137 |
| hERG | 0.031 |
| Ames | 0.005 |
| ROA | 0.013 |
| SkinSen | 0.952 |
| Carcinogencity | 0.132 |
| EI | 0.823 |
| Respiratory | 0.946 |
| NR-Aromatase | 0.319 |
| Antiviral | Yes |
| Prediction | 0.594568 |